Cardio Diagnostics Holdings Inc (CDIO) Live Share Price, Invest From India

Cardio Diagnostics Holdings Inc Stock Performance

as on May 23, 2026 at 2:16 pm IST

Day's Low
Day's High
$1.56
Day's Price Range
$1.67
$1.61
3.11%
Downside
3.73%
Upside
52 Week's Low
52 Week's High
$0.97
52-Week Price Range
$7.91
$1.61
39.75%
Downside
391.30%
Upside

Cardio Diagnostics Holdings Inc share price movements today

Previous Close: $1.51
Open: $1.60
Volume: 639.0K
Day's Low - High: $1.56 - $1.67
52 Week Low - High: $0.97 - $7.91

Cardio Diagnostics Holdings Inc Historical Returns

1 Month Return: -20.94 %
3 Month Return: -47.57 %
1 Year Return: -64.39 %
3 Year Return: -96.71 %
5 Year Return: 0 %

Cardio Diagnostics Holdings Inc Stock Fundamentals & Key Indicators

Check Cardio Diagnostics Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.5M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-6.1M

Revenue (TTM)

14.8K

Profit Margin

0.00%

Return On Equity TTM

-78.62%

Cardio Diagnostics Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cardio Diagnostics Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cardio Diagnostics Holdings Inc	BUY	$4.5M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.9B	114.56%	75.18	12.55%
Vertex Pharmaceuticals Inc	BUY	$109.2B	103.13%	25.58	35.51%
Regeneron Pharmaceuticals Inc	BUY	$68.1B	26.81%	15.87	29.65%

Stock Returns calculator for Cardio Diagnostics Holdings Inc Stock including INR - Dollar returns

The Cardio Diagnostics Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Cardio Diagnostics Holdings Inc investment value today

Current value as on today

₹42,643

Returns

-₹57,357

(-57.36%)

Returns from Cardio Diagnostics Holdings Inc Stock

-₹62,028 (-62.03%)

Dollar Impact

₹4,671 (+4.67%)

Analyst Recommendation on Cardio Diagnostics Holdings Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Cardio Diagnostics Holdings Inc. Average target price of $60

Cardio Diagnostics Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Cardio Diagnostics Holdings Inc.

What analysts predicted

97.32%UPSIDE

Target Price

$60

Current Price

$1.61

Analyzed by

8 Analysts

Target

$60.00

Cardio Diagnostics Holdings Inc target price $60, a slight upside of 97.32% compared to current price of $1.61. According to 8 analysts rating.

Indian Investors' Interest in Cardio Diagnostics Holdings Inc Stock

Search interest for Cardio Diagnostics Holdings Inc Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 23, 2026 to May 23, 2026

Change:-55% versus previous 30 day period

Cardio Diagnostics Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	-	0	0	0	0	0	0	0	0	0
Operating Income	-1	-4	-1	-1	-1	-1	-1	-1	-1	-1
EBITDA	-	-4	-1	-1	-1	-1	-1	-1	-1	-1
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-4	-1	-1	-1	-1	-1	-1	-1	-1
Income Tax Expense	-	-	0	-	-	-	-	-	-	-
Net Income	-1	-4	-1	-1	-1	-1	-1	-1	-1	-1
Net Profit Margin	-26156.85%	-26140.03%	-16365.88%	-21467.57%	-33672.61%	-173942.98%	-22517.71%	-60053.80%	-41219.92%	-66722.31%

Cardio Diagnostics Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	0	0	0	0	0
Gross Profit	-	0	0	0	0	0
Operating Income	0	0	-4	-7	-8	-6
EBITDA	0	0	-4	-1	-8	-6
Interest Expense	-	-	-	6	0	0
Depreciation	0	0	0	0	0	0
Income Before Tax	0	0	-4	-8	-8	-6
Income Tax Expense	-	0	0	-	-	-
Net Income	0	0	-4	-8	-8	-6
Net Profit Margin	0.00%	-68862.15%	-490630.00%	-49087.81%	-24028.24%	-43832.49%

Cardio Diagnostics Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-4	-1	-1	-1	-1	-1	-1	-1	-1
Operating Cash Flow	-1	-1	-1	-1	-1	-1	-1	-1	-1
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	1	1	1	7	3	0	0	0	3
Change in Cash	0	0	0	5	1	-1	-1	-1	1

Cardio Diagnostics Holdings Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	0	-4	-8	-8	-6
Operating Cash Flow	0	-5	-5	-4	-5
Investing Cash Flow	0	0	0	0	0
Financing Cash Flow	1	9	3	11	3
Change in Cash	0	3	-2	6	-2

Global Institutional Holdings in Cardio Diagnostics Holdings Inc

Funds	Holdings
Geode Capital Management, LLC	0.51%
Morgan Stanley - Brokerage Accounts	0%
Wolverine Asset Management LLC	0%
FMR Inc	0%
Advisor Group Holdings, Inc.	0%

See all

Insights on Cardio Diagnostics Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Cardio Diagnostics Holdings Inc. Common stock has experienced a drawdown of -96.4%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 82.2%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 9.2% return, outperforming this stock by 71.0%
NEGATIVE IMPACT
Price Dip
In the last 3 months, CDIO stock has moved down by -49.8%

About Cardio Diagnostics Holdings Inc

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Organisation	Cardio Diagnostics Holdings Inc
Headquarters	311 West Superior Street, Chicago, IL, United States, 60654
Industry	Biotechnology
CEO	Dr. Meeshanthini V. Dogan Ph.D.
E-voting on shares	Click here to vote

Key Management of Cardio Diagnostics Holdings Inc

Name	Title
Dr. Meeshanthini V. Dogan Ph.D.	Co-Founder, CEO & Director
Ms. Elisa Michael Luqman Esq., J.D., M.B.A.	CFO & Principal Accounting Officer
Mr. Timur Dogan Ph.D.	Chief Technology Officer
Dr. Robert A. Philibert M.D., Ph.D.	Co-Founder, Chief Medical Officer & Director

FAQs

What is Cardio Diagnostics Holdings Inc share price today?

Cardio Diagnostics Holdings Inc share price today is $1.61 as on May 23, 2026 at 8:46 am IST at the close of the market. Cardio Diagnostics Holdings Inc share today touched a day high of $1.67 and a low of $1.56.

What is the 52 week high and 52 week low for Cardio Diagnostics Holdings Inc share?

Cardio Diagnostics Holdings Inc share touched a 52 week high of $7.91 on February 27, 2026 and a 52 week low of $0.97 on February 6, 2026. Cardio Diagnostics Holdings Inc stock price today i.e. May 23, 2026 at 8:46 am IST is closed at $1.61,which is 79.65% down from its 52 week high and 65.98% up from its 52 week low.

What is Cardio Diagnostics Holdings Inc's market capitalisation today?

Cardio Diagnostics Holdings Inc market capitalisation is $0.00T as on May 23, 2026 at 8:46 am IST.

How to invest in Cardio Diagnostics Holdings Inc Stock (CDIO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cardio Diagnostics Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cardio Diagnostics Holdings Inc Shares that will get you 0.9317 shares as per Cardio Diagnostics Holdings Inc share price of $1.61 per share as on May 23, 2026 at 8:46 am IST.

What is the minimum amount required to buy Cardio Diagnostics Holdings Inc Stock (CDIO) from India?

Indian investors can start investing in Cardio Diagnostics Holdings Inc (CDIO) shares with as little as ₹95.68 or $1 (as of May 23, 2026 at 6:01 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.80 in Cardio Diagnostics Holdings Inc stock (as per the Rupee-Dollar exchange rate as on May 23, 2026 at 6:01 pm IST). Based on Cardio Diagnostics Holdings Inc share’s latest price of $1.61 as on May 23, 2026 at 8:46 am IST, you will get 6.2112 shares of Cardio Diagnostics Holdings Inc. Learn more about fractional shares .